Single- and Multiple-Dose Pharmacokinetics of an Oral Once-a-Day Osmotic Controlled-Release OROS® (methylphenidate HC1) Formulation-Reference-Cited by-同舟云学术

Single- and Multiple-Dose Pharmacokinetics of an Oral Once-a-Day Osmotic Controlled-Release OROS® (methylphenidate HC1) Formulation

Published:2000-04 Issue:4 Volume:40 Page:379-388
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Modi Nishit B.,Lindemulder Betsy,Gupta Suneel K.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Synthesis and pharmacology of hydroxylated me tabolites of methylphenidate;Patrick;J Med Chem.,1981

2. Pharmacokinetics of methylphenidate in man, rat, and monkey;Wargin;J Pharmacol Exp Ther.,1983

3. A time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity;Swanson;Pediatrics.,1978

4. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate;Shaywitz;Pediatrics.,1982

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Long-Acting Methylphenidate: Formulation Differences, Bioequivalence, Interchangeability;European Journal of Drug Metabolism and Pharmacokinetics;2023-12-21

2. Guidelines in the United States for the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Why They Are Needed;Psychiatric Annals;2023-10

3. Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder;Psychiatry Investigation;2023-09-25

4. Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management;Expert Review of Clinical Pharmacology;2023-08-22

5. A Simulation Study of the Comparative Performance of Partial Area under the Curve (pAUC) and Partial Area under the Effect Curve (pAUEC) Metrics in Crossover Versus Replicated Crossover Bioequivalence Studies for Concerta and Ritalin LA;The AAPS Journal;2022-07